An open clinical and biochemical study of ritanserin in acute patients with schizophrenia
- 1 February 1994
- journal article
- clinical trial
- Published by Springer Nature in Psychopharmacology
- Vol. 114 (1) , 31-38
- https://doi.org/10.1007/bf02245441
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A Comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor bindingInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- The role of serotonin in schizophrenia: New findingsSchizophrenia Research, 1991
- 5‐HT2 receptor antagonism in dysthymic disorder: a double‐blind placebo‐controlled study with ritanserinActa Psychiatrica Scandinavica, 1991
- 5-HT2 Antagonist Ritanserin in Neuroleptic-Induced ParkinsonismClinical Neuropharmacology, 1990
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- Zetidoline, A New AntipsychoticThe British Journal of Psychiatry, 1984
- Clinical Evaluation of Sulpiride in Schizophrenic Patients ‐ A Double‐blind Comparison with ChlorpromazineActa Psychiatrica Scandinavica, 1984
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALEActa Psychiatrica Scandinavica, 1978
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970